enVVeno Medical Corporation (NVNO)Healthcare | Medical Devices | Irvine, United States | NasdaqCM
11.00 USD
-0.38
(-3.347%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 10.91 -0.12 (-0.120%) ⇩ (July 13, 2026, 4:10 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:39 a.m. EDT
The investment case here is structurally broken. While the balance sheet appears technically liquid with minimal debt relative to cash on paper, the business fundamentals are in freefall. The company has endured six consecutive years of negative annual returns, with the most recent year seeing a nearly 30% drop in value. This is not a temporary setback; it is a multi-year structural decline where the market has repeatedly rejected the company's ability to generate value. The stock trades at a fraction of its book value, but this discount reflects the reality of negative earnings, negative free cash flow, and a failing product pipeline rather than a bargain opportunity. With no dividend to provide income and a recent earnings report confirming continued losses despite 'better-than-expected' results, the long-term outlook is dire. The single analyst rating of 'strong buy' and the $30 price target are outliers that ignore the brutal historical performance and deteriorating operational metrics. For a quantitative view, the probability of recovery is low given the persistent negative momentum and lack of institutional or retail options interest. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.138388 |
| AutoARIMA | 0.138489 |
| MSTL | 0.154273 |
| AutoTheta | 0.163837 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 0.61 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.545 |
| Excess Kurtosis | -0.65 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.539 |
| Market Cap | 7,344,359 |
| Forward P/E | -1.77 |
| Beta | 1.09 |
| Previous Name | Hancock Jaffe Laboratories, Inc. |
| Website | https://www.envveno.com |
As of July 11, 2026, 6:39 a.m. EDT: Options activity is virtually dormant with zero open interest on out-of-the-money strikes and negligible volume on in-the-money calls. This lack of speculative positioning suggests the market views the immediate future as range-bound or devoid of a clear directional thesis, offering no bullish or bearish catalyst from derivatives.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.92434233 |
| Address1 | 70 Doppler |
| All Time High | 4,935.0 |
| All Time Low | 8.67 |
| Ask | 14.04 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 8,660 |
| Average Daily Volume3 Month | 10,285 |
| Average Volume | 10,285 |
| Average Volume10Days | 8,660 |
| Beta | 1.089 |
| Bid | 8.59 |
| Bid Size | 2 |
| Book Value | 36.2 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 11.0 |
| Current Ratio | 11.894 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 12.18 |
| Day Low | 10.75 |
| Debt To Equity | 2.539 |
| Display Name | enVVeno Medical |
| Dividend Date | 1,606,694,400 |
| Earnings Timestamp End | 1,754,337,600 |
| Earnings Timestamp Start | 1,753,819,200 |
| Ebitda | -19,880,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.854 |
| Enterprise Value | -16,982,640 |
| Eps Current Year | -16.19 |
| Eps Forward | -6.22 |
| Eps Trailing Twelve Months | -31.2 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 10.53394 |
| Fifty Day Average Change | 0.46605968 |
| Fifty Day Average Change Percent | 0.044243623 |
| Fifty Two Week Change Percent | -92.434235 |
| Fifty Two Week High | 196.7 |
| Fifty Two Week High Change | -185.7 |
| Fifty Two Week High Change Percent | -0.94407725 |
| Fifty Two Week Low | 8.67 |
| Fifty Two Week Low Change | 2.33 |
| Fifty Two Week Low Change Percent | 0.26874277 |
| Fifty Two Week Range | 8.67 - 196.7 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,527,773,400,000 |
| Float Shares | 486,210 |
| Forward Eps | -6.22 |
| Forward P E | -1.7684888 |
| Free Cashflow | -8,367,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 33 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13376 |
| Held Percent Institutions | 0.25608 |
| Implied Shares Outstanding | 667,669 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,768,867,200 |
| Last Split Factor | 1:35 |
| Long Business Summary | enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. |
| Long Name | enVVeno Medical Corporation |
| Market | us_market |
| Market Cap | 7,344,359 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_28089740 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-09 |
| Net Income To Common | -18,818,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 7,584,719 |
| Number Of Analyst Opinions | 1 |
| Open | 11.36 |
| Operating Cashflow | -14,788,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 949 261 2900 |
| Post Market Change | -0.12010002 |
| Post Market Change Percent | -1.0888389 |
| Post Market Price | 10.91 |
| Post Market Time | 1,783,973,404 |
| Prev Name | Hancock Jaffe Laboratories, Inc. |
| Previous Close | 11.3809 |
| Price Eps Current Year | -0.67943174 |
| Price Hint | 2 |
| Price To Book | 0.3038674 |
| Profit Margins | 0.0 |
| Quick Ratio | 11.633 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.38090038 |
| Regular Market Change Percent | -3.3468387 |
| Regular Market Day High | 12.18 |
| Regular Market Day Low | 10.75 |
| Regular Market Day Range | 10.75 - 12.18 |
| Regular Market Open | 11.36 |
| Regular Market Previous Close | 11.3809 |
| Regular Market Price | 11.0 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 152,107 |
| Return On Assets | -0.37509 |
| Return On Equity | -0.6065 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 667,669 |
| Shares Percent Shares Out | 0.0162 |
| Shares Short | 10,784 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 70,022 |
| Short Name | enVVeno Medical Corporation |
| Short Percent Of Float | 0.0163 |
| Short Ratio | 1.38 |
| Source Interval | 15 |
| State | CA |
| Symbol | NVNO |
| Target High Price | 30.0 |
| Target Low Price | 30.0 |
| Target Mean Price | 30.0 |
| Target Median Price | 30.0 |
| Total Cash | 24,930,000 |
| Total Cash Per Share | 37.339 |
| Total Debt | 603,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -31.2 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 14.280985 |
| Two Hundred Day Average Change | -3.2809849 |
| Two Hundred Day Average Change Percent | -0.229745 |
| Type Disp | Equity |
| Volume | 152,107 |
| Website | https://www.envveno.com |
| Zip | 92,618 |